CLS A 101
Alternative Names: CLS-A-101Latest Information Update: 06 Jun 2022
Price :
$50 *
At a glance
- Originator cellus
- Class Antibodies; Antineoplastics; Immunotherapies
- Mechanism of Action Chemokine CXCL16 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Triple negative breast cancer